Condensed Consolidated Statement of Shareholders' Investment (Unaudited) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Increase (Decrease) in Shareholders' Investment
Beginning balance			$ 38,827
Net earnings	$ 1,646	$ 1,436	4,173	$ 4,129
Other comprehensive income (loss)	331	(409)	35	(429)
Ending balance	40,028		40,028
Common Shares
Increase (Decrease) in Shareholders' Investment
Beginning balance	24,858	24,612	24,869	24,709
Issued under incentive stock programs	48	6	148	36
Share-based compensation	117	116	563	531
Issuance of restricted stock awards	(3)	(7)	(560)	(549)
Ending balance	25,020	24,727	25,020	24,727
Common Shares Held in Treasury
Increase (Decrease) in Shareholders' Investment
Beginning balance	(15,759)	(15,722)	(15,981)	(15,229)
Issued under incentive stock programs	35	36	279	288
Purchased	(752)	0	(774)	(745)
Ending balance	(16,476)	(15,686)	(16,476)	(15,686)
Earnings Employed in the Business
Increase (Decrease) in Shareholders' Investment
Beginning balance	38,354	36,355	37,554	35,257
Net earnings	1,646	1,436	4,173	4,129
Cash dividends declared on common shares	(958)	(889)	(2,879)	(2,668)
Effect of common and treasury share transactions	14	18	208	202
Ending balance	39,056	36,920	39,056	36,920
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Shareholders' Investment
Beginning balance	(8,135)	(8,071)	(7,839)	(8,051)
Other comprehensive income (loss)	331	(409)	35	(429)
Ending balance	(7,804)	(8,480)	(7,804)	(8,480)
Noncontrolling Interests in Subsidiaries
Increase (Decrease) in Shareholders' Investment
Beginning balance	242	230	224	219
Noncontrolling Interests’ share of income, business combinations, net of distributions and share repurchases	(10)	(17)	8	(6)
Ending balance	$ 232	$ 213	$ 232	$ 213